News for Equillium, Inc. (0FY.F)

In this article we talk about 15 fastest growing biotech companies in the US. You can skip our detailed analysis of the biotech industry and go to 5 Fastest...

Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vaccine updates, M&A acti...

Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vaccine updates, M&A activity, IPO ...

LA JOLLA, Calif., Feb. 05, 2021 -- Equillium, Inc. a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders, today announced the... | February 5, 2021

LA JOLLA, Calif., Feb. 05, 2021 (GLOBE NEWSWIRE) -- Equillium, Inc. (NASDAQ:EQ) a clinical-stage biotechnology company developing itolizumab to treat severe ...

LA JOLLA, Calif., Feb. 05, 2021 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ) a clinical-stage biotechnology company developing itolizumab to treat severe

LA JOLLA, Calif., Jan. 22, 2021 (GLOBE NEWSWIRE) -- Equillium, Inc. (NASDAQ:EQ) a clinical-stage biotechnology company developing itolizumab to treat severe ...